Smart ring pioneer Oura has announced a definitive agreement to acquire AI-native primary care platform Counsel Health for $625 million. The strategic move arrives shortly after Oura decided to indefinitely postpone its highly anticipated initial public offering, which could have reached up to $2.2 billion, due to ongoing volatility and uncertainty within the broader public markets.

Counsel Health specializes in blending chat-based artificial intelligence with direct access to licensed medical professionals. The platform’s capabilities were initially integrated into the Oura application earlier this year, allowing users to receive tailored health guidance and consult directly with physicians from their mobile devices. Following the completion of the acquisition, the two entities intend to broaden their collaborative scope, pushing deeper into preventative medicine, acute treatments, and the management of chronic and specialty conditions.

The acquisition comes at a time when competition in the wearable technology sector is intensifying. While Oura has maintained a stronghold in the smart ring market, up-and-coming rivals are rapidly gaining traction, prompting the company to diversify its offerings and transition from passive health tracking to active medical intervention. Oura leadership emphasized that merging physiological data tracking with actionable clinical care will enable members to address health concerns seamlessly, ranging from routine inquiries and prescription management to lab results and specialist referrals.

As part of the transaction, Counsel CEO Muthu Alagappan will transition to Oura as the chief clinical AI officer, accompanied by the startup’s 70-person workforce. Counsel will additionally maintain its existing enterprise partnerships to scale its AI-driven care delivery model beyond the core Oura user base. The deal is slated to officially close prior to the end of 2027, bolstered by Oura’s robust financial performance, which included a 153% year-over-year quarterly revenue surge to $533 million.

Key Takeaways

• Oura is acquiring AI-native primary care startup Counsel Health for $625 million, with the transaction expected to close by late 2027.
• The acquisition follows Oura's decision to indefinitely postpone its IPO, which could have valued the company at up to $2.2 billion.
• Counsel CEO Muthu Alagappan will join Oura as chief clinical AI officer alongside 70 employees to expand preventative and chronic care integration.

Editor’s Analysis & Impact

Oura’s acquisition of Counsel Health marks a significant evolution in the wearable technology landscape, signaling a decisive shift from passive biometric monitoring to active healthcare delivery. By embedding clinical AI and direct physician access into its ecosystem, Oura is transforming its hardware into a comprehensive health management platform. This vertical integration not only helps the company fend off rising competitors in the smart ring market but also creates high-margin recurring service revenue streams. As hardware commoditization looms in the wearables sector, companies that successfully bridge the gap between consumer data and actionable medical care will likely capture long-term market dominance. However, the success of this strategy will heavily depend on navigating complex healthcare regulations and maintaining strict data privacy standards as consumer biometrics merge with clinical records.

Frequently Asked Questions

Q: How much is Oura paying to acquire Counsel Health?
A: Oura is acquiring Counsel Health for $625 million.

Q: What is the primary function of Counsel Health?
A: Counsel Health is an AI-powered healthcare platform that combines a chat-based medical experience with access to licensed physicians.

Q: When is the acquisition expected to close?
A: The deal is expected to close before the end of 2027.